In addition to psychological treatment patients had approximately weekly medical monitoring visits by experienced physicians, and 17 % were taking psychotropic medication at baseline.
Many patients were taking at least one concomitant medication at baseline (69.4%) and week 12 (50.5%).
Sustained reduction in glaucoma medication use was more likely in patients receiving at least 3 vs 1 medication at baseline (hazard ratio, 1.68; 95% CI, 1.36-2.09).
Higher negative symptom severity, higher BMI and lack of effectiveness as the reason for change of medication at baseline were baseline factors associated with a lower likelihood of achieving recovery.
CONCLUSIONS: Non-adherence with antihypertensive medication at baseline was predictive of increased systolic blood pressure up to 24 months postbaseline.
Nonadherence with any medication at baseline (hazard ratio, 1.18; 95% confidence interval, 1.11-1.25) atd at 1 year (hazard ratio, 1.19; 95% confidence interval, 1.11-1.28) were both significantly associated with an increased risk of the primary end point.
The pooled data publication do not include this information in Table 1, but the result section mention that most patients overused acute pain medication at baseline and 1.7% had opioid overuse [5].
However, Table 1 in the results section shows that approximately 2/3 of all PREEMPT 1 and 2 included participants with chronic migraine had overused acute headache pain medication at baseline [3, 4].
We contrasted the association of systolic BP, diastolic BP, number of antihypertensive medication classes taken, and indicators of frailty with risk for serious fall injuries among 5236 REGARDS study (Reasons for Geographic and Racial Difference in Stroke) participants ≥65 years taking antihypertensive medication at baseline with Medicare fee-for-service coverage.
Self-reported adherence to medication at baseline was good.
82percentt of the patients were taking medication at baseline.
